A Robust Portfolio of Cancer Clinical Trials
Adult Clinical Trials
View all active adult clinical trials available through the Froedtert & the Medical College of Wisconsin Cancer Network.
Pediatric Clinical Trials
Find a list of clinical trials available through Children’s Wisconsin as well as questions for your care team.
Physician Referrals
Visit MCW Physician ACCESS (All Cancer Enrolling Studies) to locate a potential match for adult and pediatric patients.
A Leader in Cancer Clinical Trials
The National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN) designated the MCW Cancer Center as a Lead Academic Participating Site (LAPS) for the strength and innovation of its ongoing research and science and robust participation in its clinical trials.
The MCW Cancer Center is one of only 32 institutions in the United States to achieve this designation, and the only institution in Milwaukee and the eastern Wisconsin region.
Innovative Neuroimaging Technique Could Improve Outcomes for Patients with Glioblastoma
An innovative approach known as radiopathomic mapping combines advanced imaging technology with artificial intelligence to provide a more accurate and comprehensive understanding of how tumors evolve over time, leading to better, more targeted treatments for patients.
MCW Cancer Center Launches MyeloMATCH to Advance Precision Medicine for Myeloid Cancers
The MCW Cancer Center’s Clinical Trials Office recently activated the phase 2 MyeloMATCH screening study, that tests patients’ blood and bone marrow for biomarkers to guide treatment decisions and match them to personalized clinical trials.
PROTECT-PANC Trial Evaluates Precision Medicine Strategies in Patients with Pancreatic Cancer
Translational Research Unit Celebrates 10 Years of Accelerating Novel Cancer Therapies
Froedtert and the MCW Cancer Center recently celebrated the 10th anniversary of the Nicholas Family Foundation Translational Research Unit (TRU), the state-of-the-art clinical and research facility that has been instrumental in accelerating novel ideas and launching practice-changing cancer clinical trials.